- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/563 - ImmunoassayBiospecific binding assayMaterials therefor involving antibody fragments
Patent holdings for IPC class G01N 33/563
Total number of patents in this class: 438
10-year publication summary
|
19
|
18
|
26
|
39
|
47
|
29
|
40
|
25
|
27
|
19
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20790 |
9 |
| ARK Diagnostics, Inc. | 36 |
9 |
| IDEXX Laboratories, Inc. | 907 |
5 |
| Becton, Dickinson and Company | 7579 |
4 |
| The Brigham and Women's Hospital, Inc. | 2290 |
4 |
| Regeneron Pharmaceuticals, Inc. | 4741 |
4 |
| The Rockefeller University | 584 |
4 |
| Neuracle Science Co., Ltd. | 71 |
4 |
| Bristol-myers Squibb Company | 4747 |
3 |
| Hoffmann-La Roche Inc. | 3804 |
3 |
| Amgen Inc. | 4431 |
3 |
| Agilent Technologies, Inc. | 2638 |
3 |
| Board of Regents, The University of Texas System | 6127 |
3 |
| The Johns Hopkins University | 5898 |
3 |
| Agency for Science, Technology and Research | 3744 |
3 |
| Beckman Coulter, Inc. | 1334 |
3 |
| Five Prime Therapeutics, Inc. | 146 |
3 |
| InBios International, Inc. | 29 |
3 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3331 |
3 |
| Kagoshima University | 327 |
3 |
| Other owners | 359 |